BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30281645)

  • 1. Validation of a genetic risk score for Arkansas women of color.
    Starlard-Davenport A; Allman R; Dite GS; Hopper JL; Spaeth Tuff E; Macleod S; Kadlubar S; Preston M; Henry-Tillman R
    PLoS One; 2018; 13(10):e0204834. PubMed ID: 30281645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental impact of breast cancer SNP panel on risk classification in a screening population of white and African American women.
    McCarthy AM; Armstrong K; Handorf E; Boghossian L; Jones M; Chen J; Demeter MB; McGuire E; Conant EF; Domchek SM
    Breast Cancer Res Treat; 2013 Apr; 138(3):889-98. PubMed ID: 23474973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNPs and breast cancer risk prediction for African American and Hispanic women.
    Allman R; Dite GS; Hopper JL; Gordon O; Starlard-Davenport A; Chlebowski R; Kooperberg C
    Breast Cancer Res Treat; 2015 Dec; 154(3):583-9. PubMed ID: 26589314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants on chromosome 5p12 are associated with risk of breast cancer in African American women: the Black Women's Health Study.
    Ruiz-Narvaez EA; Rosenberg L; Rotimi CN; Cupples LA; Boggs DA; Adeyemo A; Cozier YC; Adams-Campbell LL; Palmer JR
    Breast Cancer Res Treat; 2010 Sep; 123(2):525-30. PubMed ID: 20140701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of breast cancer risk assessment tools on a French-Canadian population-based cohort.
    Jantzen R; Payette Y; de Malliard T; Labbé C; Noisel N; Broët P
    BMJ Open; 2021 Apr; 11(4):e045078. PubMed ID: 33846154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer.
    Kato I; Cichon M; Yee CL; Land S; Korczak JF
    Cancer Epidemiol; 2009 Jul; 33(1):24-30. PubMed ID: 19679043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibility loci for subtypes of breast cancer in an African American population.
    Palmer JR; Ruiz-Narvaez EA; Rotimi CN; Cupples LA; Cozier YC; Adams-Campbell LL; Rosenberg L
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):127-34. PubMed ID: 23136140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Polygenic Risk Score for Breast Cancer in US Latinas and Latin American Women.
    Shieh Y; Fejerman L; Lott PC; Marker K; Sawyer SD; Hu D; Huntsman S; Torres J; Echeverry M; Bohórquez ME; Martínez-Chéquer JC; Polanco-Echeverry G; Estrada-Flórez AP; ; Haiman CA; John EM; Kushi LH; Torres-Mejía G; Vidaurre T; Weitzel JN; Zambrano SC; Carvajal-Carmona LG; Ziv E; Neuhausen SL
    J Natl Cancer Inst; 2020 Jun; 112(6):590-598. PubMed ID: 31553449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A streamlined model for use in clinical breast cancer risk assessment maintains predictive power and is further improved with inclusion of a polygenic risk score.
    Allman R; Spaeth E; Lai J; Gross SJ; Hopper JL
    PLoS One; 2021; 16(1):e0245375. PubMed ID: 33481864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women.
    Zirpoli GR; Pfeiffer RM; Bertrand KA; Huo D; Lunetta KL; Palmer JR
    Breast Cancer Res; 2024 Jan; 26(1):2. PubMed ID: 38167144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model.
    Dite GS; Mahmoodi M; Bickerstaffe A; Hammet F; Macinnis RJ; Tsimiklis H; Dowty JG; Apicella C; Phillips KA; Giles GG; Southey MC; Hopper JL
    Breast Cancer Res Treat; 2013 Jun; 139(3):887-96. PubMed ID: 23774992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women.
    Bensen JT; Graff M; Young KL; Sethupathy P; Parker J; Pecot CV; Currin K; Haddad SA; Ruiz-Narváez EA; Haiman CA; Hong CC; Sucheston-Campbell LE; Zhu Q; Liu S; Yao S; Bandera EV; Rosenberg L; Lunetta KL; Ambrosone CB; Palmer JR; Troester MA; Olshan AF
    Breast Cancer Res; 2018 Jun; 20(1):45. PubMed ID: 29871690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry.
    Dite GS; MacInnis RJ; Bickerstaffe A; Dowty JG; Allman R; Apicella C; Milne RL; Tsimiklis H; Phillips KA; Giles GG; Terry MB; Southey MC; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):359-65. PubMed ID: 26677205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.
    Udler MS; Meyer KB; Pooley KA; Karlins E; Struewing JP; Zhang J; Doody DR; MacArthur S; Tyrer J; Pharoah PD; Luben R; Bernstein L; Kolonel LN; Henderson BE; Le Marchand L; Ursin G; Press MF; Brennan P; Sangrajrang S; Gaborieau V; Odefrey F; Shen CY; Wu PE; Wang HC; Kang D; Yoo KY; Noh DY; Ahn SH; Ponder BA; Haiman CA; Malone KE; Dunning AM; Ostrander EA; Easton DF;
    Hum Mol Genet; 2009 May; 18(9):1692-703. PubMed ID: 19223389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of breast cancer risk based on profiling with common genetic variants.
    Mavaddat N; Pharoah PD; Michailidou K; Tyrer J; Brook MN; Bolla MK; Wang Q; Dennis J; Dunning AM; Shah M; Luben R; Brown J; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Czene K; Darabi H; Eriksson M; Peto J; Dos-Santos-Silva I; Dudbridge F; Johnson N; Schmidt MK; Broeks A; Verhoef S; Rutgers EJ; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; Figueroa J; Chanock SJ; Brinton L; Lissowska J; Couch FJ; Olson JE; Vachon C; Pankratz VS; Lambrechts D; Wildiers H; Van Ongeval C; van Limbergen E; Kristensen V; Grenaker Alnæs G; Nord S; Borresen-Dale AL; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Fasching PA; Haeberle L; Ekici AB; Beckmann MW; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Trentham-Dietz A; Newcomb P; Titus L; Egan KM; Hunter DJ; Lindstrom S; Tamimi RM; Kraft P; Rahman N; Turnbull C; Renwick A; Seal S; Li J; Liu J; Humphreys K; Benitez J; Pilar Zamora M; Arias Perez JI; Menéndez P; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Bogdanova NV; Antonenkova NN; Dörk T; Anton-Culver H; Neuhausen SL; Ziogas A; Bernstein L; Devilee P; Tollenaar RA; Seynaeve C; van Asperen CJ; Cox A; Cross SS; Reed MW; Khusnutdinova E; Bermisheva M; Prokofyeva D; Takhirova Z; Meindl A; Schmutzler RK; Sutter C; Yang R; Schürmann P; Bremer M; Christiansen H; Park-Simon TW; Hillemanns P; Guénel P; Truong T; Menegaux F; Sanchez M; Radice P; Peterlongo P; Manoukian S; Pensotti V; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Brauch H; Brüning T; Ko YD; Sigurdson AJ; Doody MM; Hamann U; Torres D; Ulmer HU; Försti A; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Andrulis IL; Knight JA; Glendon G; Marie Mulligan A; Chenevix-Trench G; Balleine R; Giles GG; Milne RL; McLean C; Lindblom A; Margolin S; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Eilber U; Wang-Gohrke S; Hooning MJ; Hollestelle A; van den Ouweland AM; Koppert LB; Carpenter J; Clarke C; Scott R; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Brenner H; Arndt V; Stegmaier C; Karina Dieffenbach A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Offit K; Vijai J; Robson M; Rau-Murthy R; Dwek M; Swann R; Annie Perkins K; Goldberg MS; Labrèche F; Dumont M; Eccles DM; Tapper WJ; Rafiq S; John EM; Whittemore AS; Slager S; Yannoukakos D; Toland AE; Yao S; Zheng W; Halverson SL; González-Neira A; Pita G; Rosario Alonso M; Álvarez N; Herrero D; Tessier DC; Vincent D; Bacot F; Luccarini C; Baynes C; Ahmed S; Maranian M; Healey CS; Simard J; Hall P; Easton DF; Garcia-Closas M
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25855707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
    Mealiffe ME; Stokowski RP; Rhees BK; Prentice RL; Pettinger M; Hinds DA
    J Natl Cancer Inst; 2010 Nov; 102(21):1618-27. PubMed ID: 20956782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Projecting individualized absolute invasive breast cancer risk in African American women.
    Gail MH; Costantino JP; Pee D; Bondy M; Newman L; Selvan M; Anderson GL; Malone KE; Marchbanks PA; McCaskill-Stevens W; Norman SA; Simon MS; Spirtas R; Ursin G; Bernstein L
    J Natl Cancer Inst; 2007 Dec; 99(23):1782-92. PubMed ID: 18042936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.
    Gail MH
    J Natl Cancer Inst; 2008 Jul; 100(14):1037-41. PubMed ID: 18612136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine-mapping of the 6q25 locus identifies a novel SNP associated with breast cancer risk in African-American women.
    Ruiz-Narváez EA; Rosenberg L; Yao S; Rotimi CN; Cupples AL; Bandera EV; Ambrosone CB; Adams-Campbell LL; Palmer JR
    Carcinogenesis; 2013 Feb; 34(2):287-91. PubMed ID: 23104177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in the mTOR pathway and breast cancer risk in African American women.
    Cheng TD; Ambrosone CB; Hong CC; Lunetta KL; Liu S; Hu Q; Yao S; Sucheston-Campbell L; Bandera EV; Ruiz-Narváez EA; Haddad S; Troester MA; Haiman CA; Bensen JT; Olshan AF; Palmer JR; Rosenberg L
    Carcinogenesis; 2016 Jan; 37(1):49-55. PubMed ID: 26577839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.